Bell's palsy: Aetiology, clinical features and multidisciplinary care

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 86, Issue 12, 2015, Pages 1356-1361

  Eviston, Timothy J ^a   Croxson, Glen R ^b   Kennedy, Peter G E ^c   Hadlock, Tessa ^d   Krishnan, Arun V ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; BOTULINUM TOXIN; CORTICOSTEROID; PLACEBO; PREDNISONE; STEROID; VALACICLOVIR;

BELL PALSY; CELLULAR IMMUNITY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE SEVERITY; DRUG INDICATION; ELECTRONEUROGRAPHY; ESTHETICS; EYE CARE; FACIAL NERVE PARALYSIS; FREE TISSUE GRAFT; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HUMAN; MOUTH HYGIENE; NERVE TRANSPLANTATION; NEUROPATHOLOGY; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PHYSICAL EXAMINATION; PHYSIOTHERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SOCIAL STATUS; STEROID THERAPY; SYNKINESIS; VARICELLA ZOSTER VIRUS; VIRUS CELL INTERACTION; VIRUS REACTIVATION; WALLERIAN DEGENERATION; HISTORY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY;

BELL PALSY; COMBINED MODALITY THERAPY; HISTORY, 19TH CENTURY; HUMANS;

EID: 84956583079     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-309563     Document Type: Review

References (40)

1. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;122:4-30.
2. Diamond M, Wartmann CT, Tubbs RS, et al. Peripheral facial nerve communications and their clinical implications. Clin Anat 2011;24:10-18.
3. Adour KK, Byl FM, Hilsinger RL Jr, et al. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope 1978;88:787-801.
4. Kennedy PG. Herpes simplex virus type 1 and Bell's palsy - a current assessment of the controversy. J Neurovirol 2010;16:1-5.
5. McCormick DP. Herpes-simplex virus as cause of Bell's palsy. Lancet 1972;299:937-9.
6. Gantz BJ, Rubinstein JT, Gidley P, et al. Surgical management of Bell's palsy. Laryngoscope 1999;109:1177-88.
7. Greco A, Gallo A, Fusconi M, et al. Bell's palsy and autoimmunity. Autoimmun Rev 2012;12:323-8.
8. Sajadi MM, Sajadi M-RM, Tabatabaie SM. The history of facial palsy and spasm: hippocrates to Razi. Neurology 2011;77:174-8.
9. Canalis RF, Cino L. Ceramic representations of facial paralysis in ancient Peru. Otol Neurotol 2003;24:828-31.
10. De Diego JI, Prim MP, Madero R, et al. Seasonal patterns of idiopathic facial paralysis: a 16-year study. Otolaryngol Head Neck Surg 1999;120:269-71.
11. Lewis DJM, Huo Z, Barnett S, et al. Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS ONE 2009;4:e6999.
12. Campbell KE, Brundage JF. Effects of climate, latitude, and season on the incidence of Bell's palsy in the US Armed Forces, October 1997 to September 1999. Am J Epidemiol 2002;156:32-9.
13. Murakami S, Mizobuchi M, Nakashiro Y. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Inter Med 1996;124:27-30.
14. Sugita T, Murakami S, Yanagihara N. Facial nerve paralysis induced by herpes simplex virus in mice: an animal model of acute and transient facial paralysis. Ann Otol Rhinol Laryngol 1995;104:574-81.
15. Esaki S, Yamano K, Katsumi S, et al. Facial nerve palsy after reactivation of herpes simplex virus type 1 in diabetic mice. Laryngoscope 2014;125:E143-8. doi: 10.1002/lary.24994. Epub 2014 Oct 31.
16. Steiner I, Kennedy PG. Molecular biology of herpes simplex virus type 1 latency in the nervous system. Mol Neurobiol 1993;7:137-59.
17. Mitchell BM, Bloom DC, Cohrs RJ, et al. Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol 2003;9:194-204.
18. Conforti L, Gilley J, Coleman MP. Wallerian degeneration: an emerging axon death pathway linking injury and disease. Nat Rev Neurosci 2014;15:394-409.
19. Galluzzi L, Blomgren K, Kroemer G. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 2009;10:481-94.
20. Koyuncu OO, Perlman DH, Enquist LW. Efficient retrograde transport of pseudorabies virus within neurons requires local protein synthesis in axons. Cell Host Microbe 2013;13:54-66.
21. Storey N. Selective internalization of sodium channels in rat dorsal root ganglion neurons infected with herpes simplex virus-1. J Cell Biol 2002;158:1251-62.
22. Persson AK, Kim I, Zhao P, et al. Sodium channels contribute to degeneration of dorsal root ganglion neurites induced by mitochondrial dysfunction in an in vitro model of axonal injury. J Neurosci 2013;33:19250-61.
23. Croxson GR. The assessment of facial nerve dysfunction. J Otolaryng Soc Austral 1990;4:252-63.
24. Stjernquist-Desatnik A, Skoog E, Aurelius E. Detection of herpes simplex and varicella-zoster viruses in patients with Bell's palsy by the polymerase chain reaction technique. Ann Otol Rhinol Laryngol 2006;115:306-11.
25. Hohman MH, Hadlock TA. Etiology, diagnosis, and management of facial palsy: 2000 patients at a facial nerve center. Laryngoscope 2014;124:E283-93.
26. Croxson G, Coulson SE, Mukherjee P. Mistaken diagnoses in facial nerve disorders [conference presentation]. 12th International Facial Nerve Symposium. Boston: 7 June 2013.
27. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985;2:146-7.
28. Ross B, Fradet G, Nedzelski J. Development of a sensitive clinical facial grading system. Otolaryngol Head Neck Surg 1996;114:380-6.
29. Fattah AY, Gavilan J, Hadlock TA, et al. Survey of methods of facial palsy documentation in use by members of the Sir Charles Bell Society. Laryngoscope 2014;124:2247-51.
30. Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline Bell's palsy. Otolaryngol Head Neck Surg 2013;149(3 Suppl):S1-27.
31. Gronseth GS, Paduga R, American Academy of Neurology. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 2012;79:2209-13.
32. Sullivan FM, Swan IRC, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007;357:1598-607.
33. Engström M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valacyclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008;7:993-1000.
34. Salinas RA, Alvarez G, Daly F, et al. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev 2010;3:CD001942.
35. Minnerop M, Herbst M, Fimmers R, et al. Bell's palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone. J Neurol 2008;255:1726-30.
36. Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 2007;28:408-13.
37. Robinson M, Hadlock TA. Comprehensive facial rehabilitation improves function in people with facial paralysis: a 5-year experience at the Massachusetts Eye and Ear Infirmary. Phys Ther 2010;90:391-7.
38. Hadlock TA, Greenfield LJ, Wernick-Robinson M, et al. Multimodality approach to management of the paralyzed face. Laryngoscope 2006;116:1385-9.
39. Hohman MH, Lee LN, Hadlock TA. Two-step highly selective neurectomy for refractory periocular synkinesis. Laryngoscope 2013;123:1385-8.
40. Labbé D, Bénateau H, Bardot J. Surgical procedures for labial reanimation in facial paralysis. Ann Chir Plast Esthet 2002;47:580-91.